186 related articles for article (PubMed ID: 9576068)
1. Modulation of cartilage proteoglycan metabolism by LIF binding protein.
Hui W; Bell MC; Carroll GJ; Layton MJ
Cytokine; 1998 Mar; 10(3):220-6. PubMed ID: 9576068
[TBL] [Abstract][Full Text] [Related]
2. Soluble glycoprotein 130 (gp130) attenuates OSM- and LIF-induced cartilage proteoglycan catabolism.
Hui W; Bell M; Carroll G
Cytokine; 2000 Feb; 12(2):151-5. PubMed ID: 10671300
[TBL] [Abstract][Full Text] [Related]
3. Oncostatin M (OSM) stimulates resorption and inhibits synthesis of proteoglycan in porcine articular cartilage explants.
Hui W; Bell M; Carroll G
Cytokine; 1996 Jun; 8(6):495-500. PubMed ID: 8818547
[TBL] [Abstract][Full Text] [Related]
4. Leukemia inhibitory factor (LIF) binding protein attenuates the phlogistic and abolishes the chondral effects of LIF in goat joints.
Bell M; Carroll GJ; Chapman H; Layton M; Mills J
J Rheumatol; 1997 Dec; 24(12):2394-402. PubMed ID: 9415649
[TBL] [Abstract][Full Text] [Related]
5. Rheumatoid synovial fluid contains bioactive leukemia inhibitory factor with cartilage degrading activity--another target for chondroprotective intervention.
Bell MC; Carroll GJ
J Rheumatol; 2000 Feb; 27(2):332-8. PubMed ID: 10685793
[TBL] [Abstract][Full Text] [Related]
6. AIDS-associated Kaposi's sarcoma (KS) cells express oncostatin M (OM)-specific receptor but not leukemia inhibitory factor/OM receptor or interleukin-6 receptor. Complete block of OM-induced KS cell growth and OM binding by anti-gp130 antibodies.
Murakami-Mori K; Taga T; Kishimoto T; Nakamura S
J Clin Invest; 1995 Sep; 96(3):1319-27. PubMed ID: 7657807
[TBL] [Abstract][Full Text] [Related]
7. Oncostatin M is a differentiation factor for myeloid leukemia cells.
Bruce AG; Hoggatt IH; Rose TM
J Immunol; 1992 Aug; 149(4):1271-5. PubMed ID: 1380037
[TBL] [Abstract][Full Text] [Related]
8. Leukaemia inhibitory factor (LIF) suppresses proteoglycan synthesis in porcine and caprine cartilage explants.
Bell MC; Carroll GJ
Cytokine; 1995 Feb; 7(2):137-41. PubMed ID: 7780032
[TBL] [Abstract][Full Text] [Related]
9. Oncostatin M-specific receptor expression and function in regulating cell proliferation of normal and malignant mammary epithelial cells.
Liu J; Hadjokas N; Mosley B; Estrov Z; Spence MJ; Vestal RE
Cytokine; 1998 Apr; 10(4):295-302. PubMed ID: 9617575
[TBL] [Abstract][Full Text] [Related]
10. Effect of interleukin 1 and leukaemia inhibitory factor on chondrocyte metabolism in articular cartilage from normal and interleukin-6-deficient mice: role of nitric oxide and IL-6 in the suppression of proteoglycan synthesis.
Van de Loo FA; Arntz OJ; Van den Berg WB
Cytokine; 1997 Jul; 9(7):453-62. PubMed ID: 9237807
[TBL] [Abstract][Full Text] [Related]
11. Oncostatin M binds the high-affinity leukemia inhibitory factor receptor.
Gearing DP; Bruce AG
New Biol; 1992 Jan; 4(1):61-5. PubMed ID: 1536831
[TBL] [Abstract][Full Text] [Related]
12. Oncostatin M induces leukocyte infiltration and cartilage proteoglycan degradation in vivo in goat joints.
Bell MC; Carroll GJ; Chapman HM; Mills JN; Hui W
Arthritis Rheum; 1999 Dec; 42(12):2543-51. PubMed ID: 10615999
[TBL] [Abstract][Full Text] [Related]
13. Are LIF and related cytokines functionally equivalent?
Piquet-Pellorce C; Grey L; Mereau A; Heath JK
Exp Cell Res; 1994 Aug; 213(2):340-7. PubMed ID: 8050491
[TBL] [Abstract][Full Text] [Related]
14. The upper cytokine-binding module and the Ig-like domain of the leukaemia inhibitory factor (LIF) receptor are sufficient for a functional LIF receptor complex.
Aasland D; Oppmann B; Grötzinger J; Rose-John S; Kallen KJ
J Mol Biol; 2002 Jan; 315(4):637-46. PubMed ID: 11812136
[TBL] [Abstract][Full Text] [Related]
15. Oncostatin M-specific receptor mediates inhibition of breast cancer cell growth and down-regulation of the c-myc proto-oncogene.
Liu J; Spence MJ; Wallace PM; Forcier K; Hellström I; Vestal RE
Cell Growth Differ; 1997 Jun; 8(6):667-76. PubMed ID: 9186000
[TBL] [Abstract][Full Text] [Related]
16. GP130/OSMR is the only LIF/IL-6 family receptor complex to promote osteoblast differentiation of calvaria progenitors.
Malaval L; Liu F; Vernallis AB; Aubin JE
J Cell Physiol; 2005 Aug; 204(2):585-93. PubMed ID: 15751050
[TBL] [Abstract][Full Text] [Related]
17. Specific binding of leukemia inhibitory factor to murine myoblasts in culture.
Bower J; Vakakis N; Nicola NA; Austin L
J Cell Physiol; 1995 Jul; 164(1):93-8. PubMed ID: 7790402
[TBL] [Abstract][Full Text] [Related]
18. Oncostatin M synergises with house dust mite proteases to induce the production of PGE(2) from cultured lung epithelial cells.
Knight DA; Asokananthan N; Watkins DN; Misso NL; Thompson PJ; Stewart GA
Br J Pharmacol; 2000 Oct; 131(3):465-72. PubMed ID: 11015296
[TBL] [Abstract][Full Text] [Related]
19. Leukaemia inhibitory factor stimulates proteoglycan resorption in porcine articular cartilage.
Carroll GJ; Bell MC
Rheumatol Int; 1993; 13(1):5-8. PubMed ID: 8516624
[TBL] [Abstract][Full Text] [Related]
20. The presence in human serum of a circulating soluble leukemia inhibitory factor receptor (sgp190) and its evolution during pregnancy.
Pitard V; Lorgeot V; Taupin JL; Aubard Y; Praloran V; Moreau JF
Eur Cytokine Netw; 1998 Dec; 9(4):599-605. PubMed ID: 9889403
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
